Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Etoposide × Other solid neoplasm × Clear all

Phase

Phase 1 15 Phase 2 9 Phase 3 3 Phase 1/2 3 Phase NA 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 15 Other hematologic neoplasm 10 CNS 3 Myeloid 2 Dermatologic 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Classical hematology 1

Conditions

Retinoblastoma 1

Interventions

pembrolizumab 3 Pemetrexed 2 Drug Therapy 2 Cisplatin 2 toripalimab 1 tislelizumab 1 spartalizumab 1 sintilimab 1 penpulimab 1 nintedanib 1 camrelizumab 1 balstilimab 1 atezolizumab 1 anlotinib 1 Vincristine 1 Topotecan 1 Sentinel Lymph Node Biopsy 1 Platinum Compounds 1 Melphalan 1 Inosine 1 Injections 1 Indocyanine Green 1 Immunotherapy 1 Hyperthermia, Induced 1 Etoposide 1 Cryotherapy 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡